79 related articles for article (PubMed ID: 22020339)
21. JunB is a key regulator of multiple myeloma bone marrow angiogenesis.
Fan F; Malvestiti S; Vallet S; Lind J; Garcia-Manteiga JM; Morelli E; Jiang Q; Seckinger A; Hose D; Goldschmidt H; Stadlbauer A; Sun C; Mei H; Pecherstorfer M; Bakiri L; Wagner EF; Tonon G; Sattler M; Hu Y; Tassone P; Jaeger D; Podar K
Leukemia; 2021 Dec; 35(12):3509-3525. PubMed ID: 34007044
[TBL] [Abstract][Full Text] [Related]
22. Activating transcription factor 3 inhibits endometrial carcinoma aggressiveness via JunB suppression.
Wang F; Li J; Wang H; Zhang F; Gao J
Int J Oncol; 2020 Sep; 57(3):707-720. PubMed ID: 32582999
[TBL] [Abstract][Full Text] [Related]
23. PKCθ-JunB axis via upregulation of VEGFR3 expression mediates hypoxia-induced pathological retinal neovascularization.
Kumar R; Mani AM; Singh NK; Rao GN
Cell Death Dis; 2020 May; 11(5):325. PubMed ID: 32382040
[TBL] [Abstract][Full Text] [Related]
24. Angiogenesis in odontogenic keratocyst and dentigerous cyst: Evaluation of JunB and VEGF expression.
Sadri D; Farhadi S; Nourmohamadi P
Dent Res J (Isfahan); 2019; 16(5):327-332. PubMed ID: 31543939
[TBL] [Abstract][Full Text] [Related]
25. Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors.
Argyle D; Kitamura T
Front Immunol; 2018; 9():2629. PubMed ID: 30483271
[TBL] [Abstract][Full Text] [Related]
26. VHL and Hypoxia Signaling: Beyond HIF in Cancer.
Zhang J; Zhang Q
Biomedicines; 2018 Mar; 6(1):. PubMed ID: 29562667
[TBL] [Abstract][Full Text] [Related]
27. Control of endothelial cell tube formation by Notch ligand intracellular domain interactions with activator protein 1 (AP-1).
Forghany Z; Robertson F; Lundby A; Olsen JV; Baker DA
J Biol Chem; 2018 Jan; 293(4):1229-1242. PubMed ID: 29196606
[TBL] [Abstract][Full Text] [Related]
28. Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.
Yang S; Chen L; Chan DW; Li QK; Zhang H
Clin Proteomics; 2017; 14():31. PubMed ID: 28814946
[TBL] [Abstract][Full Text] [Related]
29. The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment.
Fan F; Bashari MH; Morelli E; Tonon G; Malvestiti S; Vallet S; Jarahian M; Seckinger A; Hose D; Bakiri L; Sun C; Hu Y; Ball CR; Glimm H; Sattler M; Goldschmidt H; Wagner EF; Tassone P; Jaeger D; Podar K
Leukemia; 2017 Jul; 31(7):1570-1581. PubMed ID: 27890927
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA expression profile of infantile hemangioma identified by microarray analysis.
Liu X; Lv R; Zhang L; Xu G; Bi J; Gao F; Zhang J; Xue F; Wang F; Wu Y; Fu C; Wang Q; Huo R
Tumour Biol; 2016 Oct; ():. PubMed ID: 27709553
[TBL] [Abstract][Full Text] [Related]
31. CCL2 as a potential therapeutic target for clear cell renal cell carcinoma.
Arakaki R; Yamasaki T; Kanno T; Shibasaki N; Sakamoto H; Utsunomiya N; Sumiyoshi T; Shibuya S; Tsuruyama T; Nakamura E; Ogawa O; Kamba T
Cancer Med; 2016 Oct; 5(10):2920-2933. PubMed ID: 27666332
[TBL] [Abstract][Full Text] [Related]
32. Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
Küper C; Beck FX; Neuhofer W
Oncol Lett; 2016 Sep; 12(3):2201-2209. PubMed ID: 27602164
[TBL] [Abstract][Full Text] [Related]
33. Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance.
Razafinjatovo C; Bihr S; Mischo A; Vogl U; Schmidinger M; Moch H; Schraml P
BMC Cancer; 2016 Aug; 16():638. PubMed ID: 27530247
[TBL] [Abstract][Full Text] [Related]
34. AP-1 transcription factor mediates VEGF-induced endothelial cell migration and proliferation.
Jia J; Ye T; Cui P; Hua Q; Zeng H; Zhao D
Microvasc Res; 2016 May; 105():103-8. PubMed ID: 26860974
[TBL] [Abstract][Full Text] [Related]
35. JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma.
Hyakusoku H; Sano D; Takahashi H; Hatano T; Isono Y; Shimada S; Ito Y; Myers JN; Oridate N
J Exp Clin Cancer Res; 2016 Jan; 35():6. PubMed ID: 26754630
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney Cancer.
Salama R; Masson N; Simpson P; Sciesielski LK; Sun M; Tian YM; Ratcliffe PJ; Mole DR
PLoS One; 2015; 10(8):e0134645. PubMed ID: 26262842
[TBL] [Abstract][Full Text] [Related]
37. Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.
Shibasaki N; Yamasaki T; Kanno T; Arakaki R; Sakamoto H; Utsunomiya N; Inoue T; Tsuruyama T; Nakamura E; Ogawa O; Kamba T
PLoS One; 2015; 10(6):e0130980. PubMed ID: 26114873
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells.
Zhang J; Liu C; Hou R
Chin J Cancer Res; 2014 Dec; 26(6):658-68. PubMed ID: 25561763
[TBL] [Abstract][Full Text] [Related]
40. Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment.
Blonska M; Zhu Y; Chuang HH; You MJ; Kunkalla K; Vega F; Lin X
Blood; 2015 Feb; 125(6):981-91. PubMed ID: 25533033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
